Developing tumors utilize multiple mechanisms to evade NK cell-mediated immune surveillance, resulting in limited access of NK cells to the tumor bed, altered NK cell phenotype and function, and loss of immunogenicity, which impedes recognition of tumor cells by NK cell receptors [122, 123]. The gene discussed is KLRD1; the disease is neoplasm.